New Healthcare Market
Objectives
By the end of this course the studente should be able:
- understand the actual situation of the health sector in global terms and in the specific case of Portugal;
-analyses potential evolution path of the health sector in global terms and in the specific case of Portugal;
-discuss the workings, advantages and disadvantages of the health systems organizations models;
-know the modalities and limits of the health sector public financing and its links with the private sector;
-identify innovations tools in health sector key areas and its potential impact;
-discuss the advantages and disadvantages of public private partnership in the health sector;
-show independence in searching and producing summaries of information on the concepts discussed during the course.
General characterization
Code
400024
Credits
4.0
Responsible teacher
José Carlos Ferreira Caiado
Hours
Weekly - Available soon
Total - Available soon
Teaching language
Portuguese. If there are Erasmus students, classes will be taught in English
Prerequisites
None
Bibliography
- Figueras,J. and Robinson, Ray,, Health System Performance, Open Unersity Press, 2006;
- Preker, A.and Harding, A., eds, Innovations in Health Services, World Bank, 2005;
- World Health Organization, Health System Financing, 2009;
- Sorenson, Corinna and Kanavos, Panos, The Role of Health Technology Assessment, European Observatory, 2008;
Teaching method
The pedagogical methodology is centered in case study process and in the interaction with the experiences of the participants.
Evaluation method
Português
Subject matter
-Health systems;
-Health concepts;
-Particularities of the health market;
-Organization models;
-Evolution of the health sector;
-The new market of health;
-NHS in the context of the new health market;
-Public and private relationship in the health systems;
-Health financing models;
-Critical factors in the dynamic of the health financing;
-Innovation: clinical innovation and information technologies innovation;
-Pharmaceutical market and innovation;
-Medical devises market and innovation;
- PPP in the health sector;